实用肿瘤学杂志 ›› 2009, Vol. 23 ›› Issue (1): 29-31.

• 论著 • 上一篇    下一篇

中晚期子宫颈小细胞癌的治疗及预后分析

殷卓敏1, 吴梅娟2, 于爱军1, 俞华1   

  1. 1.浙江省肿瘤医院妇科(杭州 310022);
    2.浙江省肿瘤医院病理科
  • 收稿日期:2008-10-06 出版日期:2009-01-20 发布日期:2012-02-21
  • 作者简介:殷卓敏, 女, (1978-), 硕士研究生, 从事妇科肿瘤放疗研究

Treatment and prognosis study of progressive small cell carcinoma of the cervix

YIN Zhuomin, WU Meijuan, YU Aijun, YU Hua.   

  1. Department of Gynecology, Zhejiang Cancer Hospital, Hangzhou 310022
  • Received:2008-10-06 Online:2009-01-20 Published:2012-02-21

摘要: 目的研究子宫颈小细胞癌(SCCC)的治疗及预后。方法 分析1997年-2005年间8例中晚期SCCC患者的临床病理资料, 临床分期ⅡB期2例, ⅢA期1例, ⅢB期3例, ⅣA期1例, ⅣB期1例, 根据患者病情采用根治性或姑息性治疗。采用Kaplan-Meier进行生存分析, 以Log-rank test确定统计上的显著差异。结果 8例中晚期SCCC患者平均无进展生存期为20.9个月, 平均总生存期为40.3个月, 3年和5年生存率分别为37.5%和25%。分期越早, 平均总生存期越长(P<0.05)。8例患者中5例发生远处转移, 远处转移率为62.5%。1例中心复发患者经过手术治疗继续生存92个月。结论 FIGO分期是中晚期SCCC患者独立预后因素。远处转移是治疗失败的主要原因。同步放化疗能改善中晚期SCCC患者预后。对于复发患者积极的挽救治疗仍可能获得较好疗效。

Abstract: Objective To study the treatment and prognosis of progressive small cell carcinoma of the cervix(SCCC).Methods 8 patients with progressive SCCC were treated from 1997 to 2005, their clinicopathologic data analyzed retrospectively.Their stages were ⅡB 2, ⅢA 1, ⅢB 3, ⅣA 1 and ⅣB 1.Radical cure or palliative therapy were adopted according to the pathogenetic condition of patients.Survival analysis was performed by using the Kaplan-Meier method.The statistical significance was determined by the log-rank test.Results The median FFS and OS were 20.9 month, 40.3 month respectively in 8 patients with progressive SCCC patients.Survival rates for 3 years and 5 years were 37.5% and 25%, respectively.The median OS were significantly longer in patients with earlier stage disease(P<0.05).Conclusions FIGO staging is solitary prognostic factor for survival.Treatment mordality of concomitant chemoradiotherapy can improve prognosis.The aggressive salvage treatment was worthwhile, patients with local recurrence could be curative.

中图分类号: